NEW YORK ( TheStreet) -- Cleveland BioLabs (CBLI - Get Report), Derma Sciences (DSCI - Get Report), Poniard Pharmaceuticals (PARD), NeurogesX (NGSX) and MediciNova (MNOV) will release their latest quarterly earnings today.Some of the above stocks recorded exponential gains during the past one year, much more than its major peers. For instance, Derma Sciences and Poniard Pharmaceuticals have accumulated 171% and 186%, respectively, while bigger names such as Johnson & Johnson (JNJ) and Pfizer (PFE) have gained 10% and 11%, respectively.
5. Cleveland BioLabs is a biotechnology company developing biodefense, tissue protection and cancer treatment drugs conceptualized on the basis of modulation of cell death for therapeutic benefit. The company's products belong to two primary families of compounds: protectans and curaxins. Protectans are drug candidates that protect healthy tissue from acute stress such as radiation, chemotherapy, and ischemia, while Curaxins are being developed as anticancer agents that could act as mono-therapy drugs, or in combination with other existing anticancer therapies.